Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,617 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Active, Not Recruiting

Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

NCT06601504

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
  • Wuhan Union Hospital of China Wuhan, Hebei, China
View all 16 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

NCT06093841

Conditions
Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more
Locations
  • Sun Yat-sen University Cancer Hospital Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

NCT05451810

Conditions
Classic Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +14 more
Locations
  • Infirmary Health - Infirmary Cancer Care at Mobile Infirmary /ID# 264630 Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 244562 Little Rock, Arkansas, United States
  • Highlands Oncology Group, PA /ID# 245002 Springdale, Arkansas, United States
  • Beverly Hills Cancer Center /ID# 255327 Beverly Hills, California, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

NCT05578976

Conditions
Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 227463 Tucson, Arizona, United States
  • Yuma Regional Medical Center /ID# 261527 Yuma, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 225703 Little Rock, Arkansas, United States
  • CBCC Global Research, Inc. /ID# 262037 Bakersfield, California, United States
View all 331 locations
View Trial Details

Related conditions